Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tong Ren Tang Technologies Co ( (HK:1666) ) just unveiled an update.
Tong Ren Tang Technologies Co. Ltd. plans to amend its Articles of Association to align with the Hong Kong Stock Exchange’s expanded paperless listing regime, ensuring its constitutional documents support hybrid general meetings and electronic voting. The move reflects the company’s effort to modernise its corporate governance framework and comply with evolving regulatory standards for listed issuers.
To maintain consistency, the board will also propose amendments to the rules of procedures of shareholders’ general meetings, with both sets of changes to be put to shareholders for approval at the 2025 annual general meeting. These governance updates are expected to facilitate more flexible shareholder participation and could enhance transparency and accessibility for investors, subject to the required special and ordinary resolutions being passed.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a Hong Kong-listed joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and traditional Chinese medicine sector. The company develops, manufactures and sells Chinese patent medicines and related health products, serving domestic and international markets through its listing on the Hong Kong Stock Exchange.
YTD Price Performance: -11.11%
Average Trading Volume: 1,000,911
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.02B
For an in-depth examination of 1666 stock, go to TipRanks’ Overview page.

